ANI Pharmaceuticals Acquires Rights to Testosterone Gel 1%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices rise 2% as US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
ANI Pharma (ANIP) Acquires NDA for Testosterone Gel 1% from Teva (TEVA)
May 13, 2015 8:02 AM EDTANI Pharmaceuticals, Inc.(NASDAQ: ANIP) announced that it has acquired the approved new drug application for a testosterone gel 1% product previously licensed to Teva Pharmaceuticals (NASDAQ: TEVA). Upon commercialization, ANI will pay Teva up to... More
